Skip to main content
NeuronFeed
/ STARTUPS

All AI startups

62 startups tracked. Filter by category, country, funding stage, or whether they have an active deal.

SORT
On this page
25
of 62 total
Funding (page)
$7.3B
combined raised
Avg score
47
0 verified · 0 with deal
More filters
Reset

Verley

France est. 2021

Precision-fermented, animal-free whey protein powered by AI bioprocess design

Drug DiscoveryAI Agriculture
Raised
$45M
Stage
S-A
51

Living Models

France est. 2024

AI foundation models for biology, starting with plant genomics

Drug Discovery
Raised
$7M
Stage
Seed
51

Superluminal Medicines

est. 2023

AI biotech company developing small-molecule drugs that target G protein-coupled receptors

Drug Discovery
Raised
$120M
Stage
S-A
51

Enjamb Labs

United States est. 2026

Full stack AI Agents accelerating Biopharma R&D

Drug Discovery
Raised
$500K
Stage
Seed
50

Trially

United States est. 2022

Agentic AI that enrolls clinical trials faster by converting patient matches

AI HealthcareDrug Discovery
Raised
$4.7M
Stage
Seed
50

RayThera

United States est. 2021

AI-driven small-molecule discovery for safer, more effective immunology drugs

Drug Discovery
Raised
$110M
Stage
S-A
50

Accipiter Biosciences

United States est. 2025

AI-designed de novo protein therapies for complex diseases

AI HealthcareDrug Discovery
Raised
$12.7M
Stage
Seed
50

Nabla Bio

United States est. 2021

Generative AI for de novo antibody and protein design against tough drug targets

Drug Discovery
Raised
$37M
Stage
S-A
49

Yoneda Labs

United States est. 2023

Foundation AI model for chemistry

Foundation ModelsDrug Discovery
Raised
$4M
Stage
Seed
49

Astraea

United States est. 2025

Agents that compress clinical trial biometrics from months to days.

AI AgentsAI Healthcare
Raised
$500K
Stage
Seed
48

Biomatter

LT est. 2019

Generative AI for protein and enzyme design across industries

Drug Discovery
Raised
$7M
Stage
Seed
48

Chemify

United Kingdom est. 2022

Digitizing chemistry with AI and robotics to make any molecule on demand

Drug DiscoveryAI Robotics
Raised
$93M
Stage
S-B
48

Isomorphic Labs

London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug

Drug Discovery
Raised
$4.8B
Stage
S-B
47

Chai Discovery

United States est. 2023

Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.

AI HealthcareDrug Discovery
Raised
$200M
Stage
S-B
46

Antiverse

United Kingdom est. 2017

Generative AI antibody design for challenging and undruggable targets

Drug Discovery
Raised
$18M
Stage
Seed
46

Genesis Therapeutics

AI drug-discovery company building generative and predictive models to design small-molecule

Drug Discovery
Raised
$344M
Stage
STRATEGIC EQUITY INVESTMENT
46

Generate:Biomedicines

PRIVATE
United States est. 2018

Generative AI for programmable protein therapeutics

AI HealthcareDrug Discovery
Raised
$700M
Stage
S-C
46

immunitoAI

est. 2020

Bengaluru-based biotech building an AI platform that designs novel antibody therapeutics from

Drug Discovery
Raised
$6.1M
Stage
S-A
45

Aqemia

French AI drug-discovery company that fuses quantum-inspired statistical mechanics with deep

Drug Discovery
Raised
$103M
Stage
S-B
45

Axiom Bio

United States est. 2023

AI models that predict human drug toxicity without animal testing

AI MedicalDrug Discovery
Raised
$15M
Stage
Seed
45

Ollin Biosciences

Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and

Drug Discovery
Raised
$100M
Stage
S-A
44

Owkin

France est. 2016

Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care.

AI AgentsAI Healthcare
Raised
$354M
Stage
S-B
43

Proscia

United States est. 2014

AI-powered digital pathology for precision medicine

AI HealthcareDrug Discovery
Raised
$130M
Stage
S-D
43

Tahoe Therapeutics

Tahoe Therapeutics, formerly Vevo Therapeutics, builds gigascale single-cell datasets to train

Drug Discovery
Raised
$30M
Stage
S-A
42

Alchemab Therapeutics

UK biotech using machine learning to mine patient-derived immune responses for protective

Drug Discovery
Raised
$32M
Stage
S-A
42